featured
Impact of Molecular Subtypes in Muscle-Invasive Bladder Cancer on Predicting Response and Survival After Neoadjuvant Chemotherapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
European Urology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Impact of Molecular Subtypes in Muscle-Invasive Bladder Cancer on Predicting Response and Survival After Neoadjuvant Chemotherapy
Eur Urol 2017 Oct 01;72(4)544-554, R Seiler, HAD Ashab, N Erho, BWG van Rhijn, B Winters, J Douglas, KE Van Kessel, EE Fransen van de Putte, M Sommerlad, NQ Wang, V Choeurng, EA Gibb, B Palmer-Aronsten, LL Lam, C Buerki, E Davicioni, G Sjödahl, J Kardos, KA Hoadley, SP Lerner, DJ McConkey, W Choi, WY Kim, B Kiss, GN Thalmann, T Todenhöfer, SJ Crabb, S North, EC Zwarthoff, JL Boormans, J Wright, M Dall'Era, MS van der Heijden, PC BlackFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.